Indian F&O data, and the evidence about what not to trade · educational
BIOCON · Healthcare
1M / 3M / 1Y
-7.9% / -5.7% / +6.3%
Traded value (60d med)
₹132 cr
Days in F&O ban since 2020
57
Futures OI / 1d change
52.2M / +0.1M
ATM implied vol
23% (vs 18% realized)
📜 Results-day history
Typical move 1.5% · up on the day 42% of 26 events · moved 4%+ in 4% · worst -5.1% / best +3.5%
| Reaction day | Move | Open gap | Next 5d | Announced |
|---|
| 2026-04-27 | +3.5% | +0.4% | -0.4% | after close |
| 2026-01-28 | +1.4% | -0.5% | -0.5% | after close |
| 2025-10-28 | +1.5% | +0.0% | +4.0% | after close |
| 2025-07-28 | -1.7% | -0.0% | -1.3% | after close |
| 2025-04-23 | +0.6% | +0.7% | -4.1% | during mkt |
| 2025-01-31 | +1.6% | -2.8% | +6.7% | during mkt |
| 2024-10-31 | -1.4% | -4.7% | +3.8% | after close |
| 2024-08-09 | -0.6% | +0.0% | +1.2% | during mkt |
Educational data reference: NOT investment advice. Historical statistics do not predict future results. We are not SEBI-registered advisers. All data from NSE public sources; figures may contain errors. Trading, especially leveraged F&O, can cause significant losses.